Skip to content

Clinical trials

Active, not recruiting Phase 2/3 trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 2/3 Status: Active, not recruiting Country / region: Netherlands Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20121
20141
20161
20172
20182
20193
20201
20213
20226
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting24

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen Research & Development, LLC3
Washington University School of Medicine2
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1
Agios Pharmaceuticals, Inc.1
Biohaven Therapeutics Ltd.1
Bristol-Myers Squibb1
Camurus AB1
Denali Therapeutics Inc.1
Eli Lilly and Company1
Geron Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease2
Dementia2
Anemia, Sickle Cell1
Blindness1
Brain Neoplasms1
Breast Neoplasms1
Carcinoma, Non-Small-Cell Lung1
Colitis, Ulcerative1
Colonic Neoplasms1
Colorectal Neoplasms1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.